Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Cash flow

278 Followers

Immuneering Cash Flow

IMRX's free cash flow for Q2 2024 was $-11.56M. For the 2024 fiscal year, IMRX's free cash flow was decreased by $-4.47M and operating cash flow was $-11.53M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -50.82M$ -48.97M$ -44.10M$ -30.85M$ -14.62M$ -4.44M
Investing Cash Flow
$ 5.52M$ 7.30M$ 41.83M$ -75.62M$ -53.41K$ -20.53K
Financing Cash Flow
$ 1.01M$ 28.44M$ 19.00K$ 144.26M$ 37.98M$ 17.17M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 253.46M$ 59.41M$ 72.64M$ 74.89M$ 37.09M$ 13.78M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 247.47K$ 28.20M-$ 120.32M$ 37.98M$ 13.40M
Issuance Of Debt
----$ 0.00$ 3.83M
Repayment Of Debt
------
Free Cash Flow
$ -51.12M$ -49.31M$ -44.84M$ -30.91M$ -14.67M$ -4.46M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Immuneering Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis